Form D · Other Technology

TwinStrand Biosciences, Inc.

Seattle, WA · CIK 0001677173

Offering snapshot reported Jun 30, 2023 · SEC filing

Reported sold
$10.3M
Offering amount: $25.7M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 20, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 30, 2023Initial$10,278,497No comparison9SEC filing
May 12, 2021Initial$49,999,943No comparisonNot reportedSEC filing
Dec 30, 2019Initial$16,301,834No comparison45SEC filing
Aug 27, 2018Initial$1,177,536No comparison23SEC filing
Sep 13, 2017Initial$5,280,338No comparison39SEC filing
Jun 24, 2016Initial$1,938,964No comparison18SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-485755
Includes shares of preferred stock issued pursuant to the cancellation of convertible notes in the amount of $2,828,504

Source: Form D, filed Jun 30, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ronnie Andrews Executive
Christopher Benoit Director, Executive
Kellie Bickel Executive
David Canner Director
Elena Cant Executive
Karen Dabbs Executive
Steve Dow Director
Michele Fernandes Executive
Chris Igielski Director, Executive
Michael Kranda Director, Executive, Promoter
Lawrence Loeb Director, Promoter
Jason Myers Director
Terry Myerson Director
Michael Pellini Director
Mike Pellini Director
Linden Rhoads Director
Jesse Salk Director, Executive, Promoter
Michael Schmitt Director, Promoter
Soma Somasegar Director
Chad Waite Director
Chad Waite, Jr. Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
3131 Elliott Avenue Suite 750
Seattle, WA, 98121